LIFELOG AND DNA

OK, geez, Wor(l)d and Toshiba... This company is still giving me goosebumps with what I am a part of and YOU can be with me! So, so powerful! Imagine knowing exactly what the food, drinks, vitamins, supplements, medications, etc are actually doing to YOUR body in real time... And can be sent straight to your doctor. We have complete total EXCLUSIVITY! And that is just the tip of the iceberg. UNREAL! Pairing our wearable with your own unique DNA = ANOTHER GAME CHANGER! And OMG what we are announcing at the CES conference! 1st time ever and a company in our industry will be at the world's largest technology conference!! WITH THE BIGGEST PRODUCT ANNOUNCEMENT EVER MADE!!

Wor(l)d is partnering up with a DNA Sequencing Company to provide a data driven approach that enables Health Care Providers to better care for their patients. Check out what Big 5 Accounting Firm thinks about the Future of Precision Medicine: Deloitte lauds Cognitive, Data-driven Health Care as the Wave of the Future to Revolutionize the $3 TRILLION US Health Care Industry. “Precision medicine” or care that is highly personalized for each person’s genome is likely to revolutionize health care of the future. And cognitive technologies will play a pivotal role, as handling the enormous amounts of data... The next 10 years will likely see a revolution in the use of cognitive technologies for health care. From an information technology perspective, cognitive technologies are probably the only resource that can make that revolutionary vision for personalized health care possible. “Precision medicine” is the shorthand term for care that is highly personalized to each individual’s genome, behavior, social, and environmental factors.... The primary focus of these initiatives is on health care providers, helping them develop treatment approaches that are most effective for individual patients. Genomic-driven medicine has already had some initial successes in fields like cancer. There are similarly transformational efforts underway among payers and life sciences companies. Payers for health care—both governmental and private sector—also have incentives to change their business models. Precision health care is based on value-based care, not the volume of treatments—which should ultimately lead to better outcomes. And not only acute or chronic care but disease prevention plans can also become personalized and more effective. Some payers are already working on individualized care plans, and some have formed new business units to create and market them. Precision medicine will likely be just as revolutionary for life sciences companies, which have already developed some drugs that are designed for specific genome profiles. Many of these companies are also analyzing genomic, metabolic, and clinical data to identify biomarkers that can facilitate early diagnosis of diseases and indicate whether a particular drug will prove effective on a particular individual."